wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28383663-97418588-6C77-46F0-A13D-1E0BF2382CB6
Q28383663-97418588-6C77-46F0-A13D-1E0BF2382CB6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28383663-97418588-6C77-46F0-A13D-1E0BF2382CB6
Novel non-AR therapeutic targets in castrate resistant prostate cancer
P2860
Q28383663-97418588-6C77-46F0-A13D-1E0BF2382CB6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28383663-97418588-6C77-46F0-A13D-1E0BF2382CB6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5d2e5e23fd0edbc198b438b2ca0270613722f653
P2860
Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.